Another way to look at this: the market values MYL at a 82% discount to what S32 valued AZ on an NPV/MC basis.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025